OncoTargets and Therapy · 2019 · 39 citations · 16 references
Life SciencesMolecular BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna BiologyNoncoding Rna FunctionNoncoding Rna In CancerTumor Suppressor GenesCancer-related Noncoding Rna FunctionLong Noncoding Rna RegulationMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerNoncoding Rna-mediated Gene RegulationSelf-renewalSelf-renewal Regulation
BACKGROUND: Of all malignancies, lung cancer is the leading cause of death, and non-small cell lung cancer (NSCLC) accounts for 80-85% of all lung cancers. In this study, the long non-coding RNA (lncRNA) THUMPD3-AS1 was observed to be highly expressed in NSCLC and correlated with TNM stages and relapse, suggesting that THUMPD3-AS1 is involved in the regulation of NSCLC. METHODS: The aim of this study was to investigate the regulatory function and mechanism of THUMPD3-AS1 in NSCLC cells by cellular function and molecular biology experiments. RESULTS: Overexpression and knockdown analysis revealed that THUMPD3-AS1 promoted tumor progression by increasing cell proliferation and self-renewal of NSCLC cells. Moreover, THUMPD3-AS1 may act as an endogenous sponge of microRNA-543 (miR-543) which can regulate the target gene ONECUT2 in NSCLC cells. CONCLUSION: Our study indicated that THUMPD3-AS1 regulated NSCLC cell self-renewal by regulating the expression of miR-543 and ONECUT2, and THUMPD3-AS1 can potentially act as a biomarker or therapeutic target in NSCLC.
16
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
ONECUT2 is a driver of neuroendocrine prostate cancer
Haiyang Guo, Xinpei Ci, Musaddeque Ahmed et al. · Nature Communications · 2019 · 244 citations · Full text
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
Mirja Rotinen, Sungyong You, Julie Yang et al. · Nature Medicine · 2018 · 189 citations · Full text